<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>6411015</identifier>
<setSpec>0020-3785</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Romero-Ayala, L C</dc:author>
<dc:author>Vidal Garate, J</dc:author>
<dc:author>Cárdenas Loaeza, M</dc:author>
<dc:description xml:lang="en">In this paper some of the new antiarrhythmic drugs are reviewed. The origin, electrophysiologic effects, mechanisms of action, pharmacokinetic properties, hemodynamic changes, clinical utilization with indications and contraindications as well as the collateral effects of: Verapamil Amiodarone, Aprindine, Encainide, Mexiletine and Tocainide are analyzed. A conclusion is drawn for each one of these drugs in accordance with the available information in the literature and the author's criteria and experience.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1983 Mar-Apr </dc:date>
<dc:title xml:lang="es">Algunos aspectos de los nuevos medicamentos antiarrítmicos.</dc:title>
<dc:title xml:lang="en">[New anti-arrhythmia drugs].</dc:title>
<dc:publisher>Archivos del Instituto de Cardiologia de Mexico</dc:publisher>
</metadata>
</record>
</pubmed-document>
